SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-078059
Filing Date
2022-07-07
Accepted
2022-07-07 16:30:42
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2217544d3_defa14a.htm DEFA14A 12477
2 GRAPHIC tm2217544d3_defa141img002.jpg GRAPHIC 28462
  Complete submission text file 0001104659-22-078059.txt   53122
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38356 | Film No.: 221071960
SIC: 2834 Pharmaceutical Preparations